CN1213739C - 含有一种泡滕系统和一种活性药用物质的粒状产品或片剂以及一种用于其制备的方法 - Google Patents

含有一种泡滕系统和一种活性药用物质的粒状产品或片剂以及一种用于其制备的方法 Download PDF

Info

Publication number
CN1213739C
CN1213739C CN95191882.6A CN95191882A CN1213739C CN 1213739 C CN1213739 C CN 1213739C CN 95191882 A CN95191882 A CN 95191882A CN 1213739 C CN1213739 C CN 1213739C
Authority
CN
China
Prior art keywords
weight
effervescent
acid
neutral substance
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95191882.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN1142182A (zh
Inventor
杰哈德·盖尔盖伊
T·盖尔盖伊
I·盖尔盖伊
S·盖尔盖伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP94203112A external-priority patent/EP0670160B1/en
Application filed by Individual filed Critical Individual
Publication of CN1142182A publication Critical patent/CN1142182A/zh
Application granted granted Critical
Publication of CN1213739C publication Critical patent/CN1213739C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN95191882.6A 1994-03-01 1995-02-23 含有一种泡滕系统和一种活性药用物质的粒状产品或片剂以及一种用于其制备的方法 Expired - Fee Related CN1213739C (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE4406641 1994-03-01
DEP4406641.4 1994-03-01
CH873/94-6 1994-03-23
CH87394 1994-03-23
CH873/946 1994-03-23
EP94203112A EP0670160B1 (en) 1994-03-01 1994-10-26 Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
EP94203112.1 1994-10-26

Publications (2)

Publication Number Publication Date
CN1142182A CN1142182A (zh) 1997-02-05
CN1213739C true CN1213739C (zh) 2005-08-10

Family

ID=27172490

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95191882.6A Expired - Fee Related CN1213739C (zh) 1994-03-01 1995-02-23 含有一种泡滕系统和一种活性药用物质的粒状产品或片剂以及一种用于其制备的方法

Country Status (15)

Country Link
JP (1) JPH09509669A (pt)
CN (1) CN1213739C (pt)
AU (1) AU681256B2 (pt)
BR (1) BR9506964A (pt)
CA (1) CA2183952C (pt)
CZ (1) CZ291710B6 (pt)
DE (1) DE670160T1 (pt)
FI (1) FI118033B (pt)
HU (1) HU228147B1 (pt)
NO (1) NO315308B1 (pt)
NZ (1) NZ281228A (pt)
PL (1) PL181714B1 (pt)
RU (1) RU2153331C2 (pt)
TW (1) TW403658B (pt)
WO (1) WO1995023594A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
AU2002350719A1 (en) * 2002-11-29 2004-06-23 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006059716A1 (ja) * 2004-12-03 2006-06-08 Takeda Pharmaceutical Company Limited 固形製剤
KR101445671B1 (ko) 2010-02-26 2014-09-29 도레이 카부시키가이샤 피복 고형 제제
ES2753129T3 (es) 2011-12-09 2020-04-07 Merck Patent Gmbh Carbonato de sodio libre de agua, con bajo contenido en poros
US20150289554A1 (en) * 2012-10-25 2015-10-15 Otc Nutrition Llc Fast Dissolving Solid Calcium Mineral Supplement Compositions and Processing Making
KR102253847B1 (ko) 2012-12-19 2021-05-21 바이엘 애니멀 헬스 게엠베하 향상된 수용성 및 우수한 저장 안정성을 가지는 정제
CN105670003A (zh) * 2014-11-21 2016-06-15 常州坤宇环保科技有限公司 高吸水树脂防结块剂
EP3318135A1 (en) * 2016-11-03 2018-05-09 Perfetti Van Melle S.p.A. Effervescent candy material, a process for its preparation and products made therefrom
CA3154949C (en) * 2019-10-17 2024-01-16 Mahesh Desai A stable effervescent co-processed excipient composition and a process for preparing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1039170A (en) * 1969-02-24 1971-07-22 Abbott Laboratories Tableting medium
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
CA2023493C (en) * 1989-08-31 2000-01-04 Masami Moroi Composition for foaming preparation
DE59201238D1 (de) * 1991-07-01 1995-03-02 Gerhard Gergely Reaktionsdotierte brausesysteme.

Also Published As

Publication number Publication date
HUT75677A (en) 1997-05-28
NO315308B1 (no) 2003-08-18
CZ251996A3 (en) 1997-01-15
CA2183952C (en) 2007-01-16
FI963385A (fi) 1996-10-30
HU228147B1 (en) 2012-12-28
PL181714B1 (en) 2001-09-28
PL316113A1 (en) 1996-12-23
FI118033B (fi) 2007-06-15
CA2183952A1 (en) 1995-09-08
DE670160T1 (de) 1996-03-14
NO963588L (no) 1996-10-31
AU1811495A (en) 1995-09-18
BR9506964A (pt) 1997-09-09
TW403658B (en) 2000-09-01
RU2153331C2 (ru) 2000-07-27
NO963588D0 (no) 1996-08-28
AU681256B2 (en) 1997-08-21
HU9602380D0 (en) 1996-10-28
FI963385A0 (fi) 1996-08-30
WO1995023594A1 (en) 1995-09-08
JPH09509669A (ja) 1997-09-30
CZ291710B6 (cs) 2003-05-14
CN1142182A (zh) 1997-02-05
NZ281228A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
CN1213739C (zh) 含有一种泡滕系统和一种活性药用物质的粒状产品或片剂以及一种用于其制备的方法
CN1163231C (zh) 用于口服的美洛西肯的盖伦制剂
CN1684665A (zh) 包含替米沙坦的固体药用制剂
CN1141097C (zh) 含有稳定化的苯并咪唑类化合物的组合物
CN1036763C (zh) 制备药物片剂和药物颗粒的方法
CN1136853C (zh) 含β-内酰胺抗生素的片剂及其制备方法
CN1056277C (zh) 含颗粒结构的片剂的制备方法
CN1024497C (zh) 一种制备西美娣定的稳定药物悬浮液的方法
CN1028962C (zh) 稳定性药物的生产方法
CN1615124A (zh) 配方
CN1185013C (zh) 赋形剂
CN1297274C (zh) 药物组合物
CN1178458A (zh) 有机组合物的改进或有关有机组合物的改进
CN1592622A (zh) 含有fexofenadine的口溶性片剂
CN1251990A (zh) 含有阿莫西林和克拉维酸盐的药物制剂
CN1871018A (zh) 包含镧化合物的药物制剂
CN1037651A (zh) 药物吸附物
CN1913876A (zh) 含药物的颗粒和包含这种颗粒的固体制剂
CN1638803A (zh) 口腔内速崩解性片剂
CN1494418A (zh) 口腔内快速崩解片剂
CN1216467A (zh) 西沙必利的速释pH－非依赖性固体剂型
CN1747723A (zh) 含活性成分混合物的组合物及其制备方法
CN1206986C (zh) 包膜马来酸三甲丁酯片剂
CN1723021A (zh) 稳定的口服固体药物组合物
CN1527700A (zh) 制备苯妥英钠剂型的压缩方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee